Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Novo Nordisk to develop compounds discovered by Indian research foundation

March 5, 1997

GelTex receives U.S. patent for CholestaGel

March 5, 1997

Antidiabetic/hypolipidemic agents from Sumitomo Metal

March 5, 1997

Pfizer develops ACAT inhibitors

March 5, 1997

First launch for troglitazone

March 4, 1997

Pramlintide delays gastric emptying in IDDM

March 4, 1997

Comparative efficacy and tolerance of s.c. and i.m. Puregon

March 4, 1997

Sumitomo Metal reveals hypoglycemic/hypolipidemic agents

March 3, 1997

Genzyme Transgenics produces protential diabetes Rx in mouse milk

Feb. 28, 1997

Preliminary clinical data reported for OP-1

Feb. 26, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Taiwan biotech looks outward in next phase of growth
BioWorld
Taiwan’s biotechnology sector was built around domestic health needs, including vaccines and drug manufacturing, but it is increasingly looking outward – to...